Multi-modality therapy leads to longer survival in primary central nervous system lymphoma patients

Canadian Journal of Neurological Sciences

Volumn 29, Issue 2, 2002, Pages 147-153

  Singhal, Dhruv ^a   Witham, Timothy F ^a   Germanwala, Anand ^a   Flickinger, John C ^a   Schiff, David ^a   Kondziolka, Douglas ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; CHOP PROTOCOL; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; BRAIN LYMPHOMA; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; STEREOTAXIC SURGERY; BRAIN TUMOR; COMPARATIVE STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; INTRASPINAL DRUG ADMINISTRATION; LARGE CELL LYMPHOMA; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NONHODGKIN LYMPHOMA; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; FEMALE; HIV-1; HUMANS; INJECTIONS, SPINAL; LYMPHOMA, LARGE-CELL, DIFFUSE; LYMPHOMA, NON-HODGKIN; MALE; METHOTREXATE; MIDDLE AGED; PREDNISONE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; VINCRISTINE;

EID: 0036018958     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0317167100120918     Document Type: Article

References (14)

1. Primary cerebral lymphomas: Unsolved issues regarding first-line treatment, follow-up, late neurological toxicity and treatment relapses
2. Update on the management of primary CNS lymphoma
3. Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: Results of a critical review of the literature
4. Risk factors for primary central nervous system lymphoma: A case-control study
5. Current management of primary central nervous system lymphoma
6. Primary central nervous system lymphoma
7. Toxicity and response criteria of the Eastern Cooperative Oncology Group
8. High dose methotrexate for treatment of primary cerebral lymphomas-analysis of survival and late neurologic toxicity in a retrospective series
9. Primary CNS lymphoma: Combined treatment with chemotherapy and radiotherapy
10. Combined modality therapy for primary CNS lymphoma
11. Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma
12. Primary central nervous system lymphoma
13. Combined modality therapy in the treatment of primary central nervous system lymphoma in AIDS
14. Biology and management of AIDS-associated primary CNS lymphomas